Kahn Brothers Group's Investment Activity Analysis: Q4 2025 Portfolio Changes

Kahn Brothers Group, managed by investors Thomas Graham, Alan Irving Kahns, saw their portfolio value reach $564.7 million as of December 31, 2025. This comprehensive analysis examines their significant stock holdings and changes during the quarter, focusing on observable purchases and sales.

The investor's largest position, Citigroup Inc (C), representing 18.11% of the portfolio, experienced a slight reduction in shares (-0.04%) during the quarter. Similarly, Merck & Co. Inc. (MRK), holding 8.02% allocation, saw a minimal decrease (-0.84%) in its position.

Several holdings showed more significant reductions. Flagstar Financial, Inc. (NYCB), which accounts for 9.31% of the portfolio, saw a notable 2.78% decrease in shares. BP PLC (BP), representing 6.39% of the portfolio, experienced a larger decline of 4.35% in shares. Seaboard Corp (SEB), with a 5.73% allocation, also saw a decrease of 5.68% in shares during the quarter.

Conversely, the investor slightly increased their position in Alphabet Inc Class C (GOOG), which holds 7.52% of the portfolio, adding 0.52% more shares. Organon & Co (OGN), representing 4.61% of the portfolio, also saw a modest increase of 0.35% in shares.

No new positions were disclosed in this filing. The investor maintained their existing positions without adding any fresh holdings during this quarter.

For a complete view of Kahn Brothers Group's portfolio and detailed filing information, please visit their profile: Kahn Brothers Group Investor Profile. Detailed information on individual stock holdings can be found at: InsiderStocks.